Cargando…
The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?
Dry powder inhalation therapy has been shown to be an effective method for treating respiratory diseases like asthma, Chronic Obstructive Pulmonary Diseases and Cystic Fibrosis. It has also been widely accepted and used in clinical practices. Such success has led to great interest in inhaled therapy...
Autores principales: | Ye, Yuqing, Ma, Ying, Zhu, Jesse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744475/ https://www.ncbi.nlm.nih.gov/pubmed/35026316 http://dx.doi.org/10.1016/j.ijpharm.2022.121457 |
Ejemplares similares
-
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
por: Xiroudaki, Styliani, et al.
Publicado: (2021) -
Feedback systems in multi-dose dry powder inhalers
por: Emeryk, Andrzej, et al.
Publicado: (2022) -
In vitro dose comparison of Respimat(®) inhaler with dry powder inhalers for COPD maintenance therapy
por: Ciciliani, Anna-Maria, et al.
Publicado: (2017) -
Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)